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Background Children often need to be administered
very small volumes of medicines that are authorised for
use in adults. Neonatal drug delivery is particularly
challenging, and doses are often immeasurable with the
equipment currently available.
Aim To summarise research to date on the accuracy of
intravenous and enteral medicine preparation requiring
small volumes (<0.1 mL), with a focus on paediatric use
and to identify areas for further work.
Method Twenty-three publications were identiﬁed for
the narrative review via: Web of Science (1950–2016),
Cumulative Index to Nursing and Allied Health Literature
(1976–2016), Excerpta Medica Database (1974–2016)
and International Pharmaceutical Abstracts (1970–2016)
searches. Nine additional papers were identiﬁed through
backward citation tracking and a further 17 were
included from the personal knowledge of the review
team.
Results Measurement of volumes (<0.1 mL), for
enteral and intravenous dosing, accounts for 25% of
medicine manipulations within paediatric hospitals.
Inaccuracies are described throughout the literature with
dose administration errors attributed to technique,
calculation, dilution and problems associated with
equipment. While standardised concentrations for
intravenous infusion and drug concentrations that avoid
measurement of small volumes would ameliorate
problems, further work is needed to establish accurate
methods for handling small volumes during the
administration of medicines to children and risk
minimisation strategies to support staff involved are also
necessary.
Conclusions This review has revealed a paucity of
information on the clinical outcomes from problems in
measuring small volumes for children and highlighted
the need for further work to eliminate this source of
inaccurate dosing and potential for medication error.
INTRODUCTION AND BACKGROUND
TO PAEDIATRIC MEDICINE
Children have historically been referred to as
‘therapeutic orphans’,1 suggesting that they were
traditionally overlooked within research into
disease and pharmacological treatment. This has
considerably limited the numbers of licensed or
authorised medicines available for children.2 In
healthcare, the term ‘children’ is often used as an
umbrella term for all subgroups of paediatric
patients and can cover preterm babies weighing
500 g to adolescents weighing 100 kg. The physio-
logical and pharmacological disparity between
them is profound, creating further challenges in
developing suitable drug therapy in this area.3
Newer legislation, such as the European Union’s
Paediatric Regulation, has been put in place as the
growing need for the development and authorisa-
tion of children’s medicines has been recognised.4
A report by the European Commission stated that
as a result of the regulation, paediatric medicine
has become an integral part of medicine develop-
ment with >600 paediatric investigation plans
(PIPs) being agreed from 2007 to 2012.4 The effect
on drug development remains to be seen due to the
lengthy nature of trials and legalities surrounding
marketing authorisation. Neonates are the most
neglected group in this population as only 30% of
current PIPs include them.4
The lack of commercially available age-appropriate
formulations makes it difﬁcult to administer medi-
cines to children accurately.5 Doses required for
children can vary 100-fold throughout childhood.
Consequently, proportions of the marketed dosage
forms are required to allow an appropriate paediat-
ric dose to be given by manipulation, often with a
medicine being used off-label.6 7 Examples of
manipulation include additional dilution of an
injection to allow the required volume to be mea-
sured accurately or to provide an accurate rate of
infusion. Manipulation occurs frequently in special-
ist and high dependency care, and research has
shown that this often leads to errors.8
Previously, 12.3% of prescribed doses of liquid
medicines (for oral and intravenous use) on neo-
natal intensive care units (NICUs) and other chil-
dren’s wards were reported as being immeasurable
with the available dosage forms.9 Additionally, only
35% of prescriptions issued on NICU use formula-
tions in a licensed way; a ﬁgure far less than in
other areas of paediatric medicine10–12 despite
advances made towards innovative drug formula-
tions for paediatric patients.4 An important conse-
quence of this is that healthcare professionals are
often required to give children very small volumes
of medicines that are licensed for use in adults.13–15
Intravenous delivery is the most widely used
method of medicine administration in very ill
preterm and term neonates and children.16
Children are exposed to potential adverse drug
events up to three times more frequently than adult
inpatients, and it is estimated that up to 54% of
these errors involve intravenous medicines.17 In
high dependency units, such as NICU, 91% of
admissions were associated with a medication error
compared with 50% of neonatal admissions to
other wards.17 Medication error rates vary widely
between studies, depending on settings and
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methods involved. In a review of 11 studies, Chedoe et al18
identiﬁed that the highest rate at which medication errors occur
in NICU was 5.5 errors per 100 prescriptions. Prescribing and
administration errors, across ﬁve different hospitals in London,
were reported on average as 13.2% and 19.1%, respectively,
and administration errors most commonly originated from
medicine preparation errors.19 Patients in this setting are at a
greater risk due to the small volumes often required; an error
that may only seem slight to the naked eye but could represent a
10-fold error or more, a scenario unlikely to occur in the adult
setting.20
Where children and medication errors are concerned, higher
risk is associated with increased vulnerability to adverse effects.
This risk is due to a number of factors: inability to communicate
effectively; a higher prevalence of rare diseases in childhood,
thus creating a lack of clinical experience in treatment; constant
physical and psychological changes over time, including intrain-
dividual and interindividual variation in drug metabolism
during growth and development; small medicine doses often
involving decimal points, thus giving opportunity for signiﬁcant
degrees of error; and errors in prescription writing due to the
lack of appropriate formulations.21–23 The need to reduce medi-
cation errors and improve patient safety in this area is clear.
METHODS
Search strategy
Searches were undertaken using four databases: Web of Science
(1950–2016), Cumulative Index to Nursing and Allied Health
Literature (1976–2016), International Pharmaceutical Abstracts
(1970–2016) and Excerpta Medica Database (1974–2016).
Limits were applied to the Web of Science search (see online
supplementary appendix A). An adaptive search strategy, based
on one developed for a previous review, was used.24 The search
strategy is presented in online supplementary appendix B.
Following the selection of publications for inclusion, backward
citation tracking was undertaken for each paper if it was
indexed in SCOPUS. Additional relevant publications were high-
lighted for inclusion by members of the review team.
Selection of papers for inclusion
Titles and abstracts were screened by one reviewer (LPA). Three
experts in the ﬁeld of paediatric and neonatal formulation
research (AJN, MAT and JLF) reviewed the titles selected to
conﬁrm that they were suitable for inclusion and to recommend
the inclusion of any additional literature known to them.
Publications were included in this review if they related to the
accuracy of intravenous and enteral medicine preparation for
children and/or involved small volumes (<0.1 mL).
RESULTS
Search results
Database searches identiﬁed 5948 unique references, of which
2313 15 19 25–44 were selected. A further nine references were
identiﬁed through backward citation tracking14 45–52 and 17
were highlighted by the review team5–9 53–64 (see online
supplementary appendix C).
Narrative review
Manipulation of medicines for intravenous and enteral use:
small volumes
Recent studies have investigated the practice of manipulating
medicines in order to provide accurate doses for children, in
particular the requirement to dilute very small volumes
(<0.5 mL).13–15 One study identiﬁed that the measurement of
volumes of <0.1 mL, for both enteral and intravenous dosing,
accounts for a quarter of medicine manipulations within paedi-
atric and neonatal hospital settings. Frequently, these volumes
are required for intravenous administration.15 Isaac et al35
found that 25% of patients on paediatric intensive care units
were prescribed a medicine that required a small volume meas-
urement of ≤0.2 mL, with the intravenous route accounting for
80% of the drug delivery methods. Uppal et al14 provide
further support, stating that 7.4% of intravenous doses require
preparation with <0.1 mL of stock solution. It was concluded
that this is necessary for the paediatric use of a wide range of
narcotics and immunosuppressants in Canada14 with captopril,
morphine, furosemide and ranitidine the most commonly found
in the UK.35
Small volume measurement and preparation for administra-
tion often involves the administrator using relevant calculations,
along with dilution and subsequent mixing with compatible
diluents, thereby introducing a potential for errors to occur. A
number of publications suggest that a high incidence of impreci-
sion and dilution errors occur in the preparation of intravenous
medicines and the preparation of small volumes of medicines is
inaccurate.13 26 41 56
What is our current understanding about the accuracy of prepared
intravenous medicines?
Morphine infusions prepared for a NICU in a UK hospital
showed concentration deviations outside of the British
Pharmacopoeia limit set for morphine sulfate injection (a
maximum of ±7.5% from the labelled concentration).26 19.2%
of infusions were outside of the limit when prepared by nurses
on the ward and 7.8% were outside this limit when made
within a pharmacy-run intravenous preparation service.
Ninety-three per cent of these ‘out of speciﬁcation’ results
occurred when volumes of ≤1 mL of morphine injection were
required to prepare the infusions.26
Furthermore, this problem was echoed in a direct observa-
tional study of a non-clinical environment in Canada, in which
healthcare professionals prepared morphine sulfate infusions.
Errors were detected at each and every stage of the preparation,
and a signiﬁcantly higher number was found when preparation
required smaller dose volumes and the use of more concentrated
solutions, that is, where more dilution was required. For
example, the use of 10 mg/mL solution to produce a required
concentration of 0.6 mg/50 mL required volume measurement
of 0.06 mL.13
Studies in anaesthesiology, where the use of intravenous medi-
cines is essential, indicated similar ﬁndings. Analyses of the
content of unused syringes containing drugs regularly used in
anaesthesiology (fentanyl, thiopental, lidocaine, atracurium)
revealed that 29% showed drug concentrations outside the spe-
ciﬁed acceptability range and 4% contained more than twice the
targeted drug concentration. Errors closely correlated with mul-
tiple dilutions of high-strength formulations, and hence mea-
surements of small volumes of initial drug solution, and these
were seen particularly in preparations involving fentanyl.41 The
complexity of preparation, often involving multiple calculations,
was implicated in dilution error. High rates of imprecision were
observed where serial dilution was required.41
Campino et al29 concluded that errors in precision were more
common than calculation errors with regard to concentrations
of tobramycin and vancomycin solutions administered on a
regional NICU. Precision errors were deﬁned as deviation
between target concentration of solution and actual concentra-
tion determined in the laboratory by >±10%. Calculation
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errors were deﬁned as the deviations between prescribed dose
and calculated dose by nurses that would theoretically be given
by >±10%. Occurrence rates were 37.9% and 4.6%,
respectively.29
A high incidence of errors, which were deﬁned as any devi-
ation from the prescription or manufacturer’s instructions
during preparation or administration, was observed during intra-
venous medicine preparation and administration in German and
UK teaching and non-teaching hospitals (48% and 49%,
respectively). Most of these errors were associated with multiple
step preparations;42 61 very small volumes and the use of
unfamiliar preparations were later identiﬁed as contributing
reasons for errors within multiple step preparations.43
Discrepancies were found between ordered and delivered
concentrations of opiates in neonatal and paediatric critical care
in Canada.39 Two-thirds of infusions were outside of the
accepted limits of variation for the study (deﬁned as ≤10%
from the ordered concentration in line with US and Canadian
pharmaceutical preparations), with 6% of infusions having a
twofold higher concentration than ordered. The inconsistencies
ranged from –78% to +210% from the desired concentration.
Speciﬁcs regarding volume measurement were not stated.39
A wide variation was ascribed, in part, between ordered and
actual concentrations of preparations of dobutamine, dopamine
and epinephrine in a paediatric intensive care unit, to a failure
to account for salt components within some formulations. Such
drugs are used in critically ill patients, and variability in dosing
could well contribute to haemodynamic instability.45 Differences
between prescribed and actual concentrations (ranging from
75.8% to 102.4% of the prescribed concentration) of vanco-
mycin infusions were also documented after investigation on a
paediatric and neonatal intensive care unit, although possible
reasons for discrepancies were not given.59
The requirement for dilution of ‘adult’ vials in order to give
paediatric doses has yielded errors in the region of 10–100-fold
from the point of prescribing to administration.36 53 Thirty-one
per cent of prescriptions on a neonatal unit required one-tenth of
a ready-made vial, and 4.8% required less than one-hundredth.30
Thus, there is evidence that small volume measurements are
often inconsistent. Our interpretation of this evidence is that
healthcare faces a very real problem. Signiﬁcant opportunities for
catastrophic medicine administration errors exist; such errors
would cause avoidable morbidity and mortality.
The preparation and administration stages involved in intra-
venous therapy involve the most error.55 62 The ability of nurses
to use calculations successfully in this process has been praised,
with a call for further investigation into other phases involved
in preparation and administration.62 Failure modes analysis sup-
ported this, and 5 out of the top 10 ‘critical failure modes’
occurred within the preparation stage.55 A systematic review of
where errors occur identiﬁed that reconstitution of drug and
diluent was a signiﬁcant area and the need for further work to
establish the most efﬁcient and accurate technique to produce
correct preparations was identiﬁed.38
Problems arising from equipment
Inaccuracies can also arise from the equipment used to prepare
paediatric doses of intravenous medicines. The dead space
within a syringe can contribute to overdosing. Dead space
volume is the volume that remains in the syringe, within the
hub and needle space, after the plunger is fully compressed and
could be inadvertently administered. For this reason, it is vital
that preparation technique is correct as it has been reported that
doses as high as 4.5 times of those recommended can
inadvertently be given. In the case of a drug with a narrow
therapeutic index such as digoxin, this can result in potentially
toxic levels.28 44 Berman et al54 noted variably high serum
levels of digoxin in low birthweight infants given similar doses
and that ﬂushing the syringe after its contents were expelled
resulted in more than twice the intended dose being adminis-
tered to the infant as the dead space volume was administered.
Furthermore, an incident occurred that involved the adminis-
tration of a bolus dose of metoclopramide that had been pre-
pared using an incorrect technique. Metoclopramide was
measured in the same syringe as subsequent sodium chloride
volume measurement; consequently, the dead space volume of
metoclopramide was also administered to a neonate, resulting in
a two to three times overdose.42
Casella et al46 reported unacceptably large errors when small
volumes, for example, 0.01 mL, were measured using 0.3 mL
insulin syringes. Coefﬁcient of variations tended to decrease as
larger volumes were measured and mean errors as large as ±2%
have been found in accuracy and reproducibility investigations,
in some cases resulting in inaccuracies of at least one syringe
division. With this said, this size of error can still be within stan-
dards set for syringes by the International Organization for
Standardization and, depending on the medicament, be consid-
ered as clinically irrelevant.48
Dosing accuracy varies depending on the brand, size of
syringe and the liquid measured. Investigating the accuracy and
reproducibility of different types of syringe used to measure
small volumes (0.05 and 0.1 mL) for intravitreal injection, vari-
ability was apparent with Nipro TB syringes yielding the best
accuracy.40 As a result, there has been a call for manufacturers
to consider dosing volumes in relation to potential patient sizes
and to also provide guidance on optimum administration
devices to use with reference to the pharmaceutical agent.34 The
cumulative error of stages involved in the preparation of intra-
venous medicines is multiplicative and therefore could be as
high as 38%, depending on what is considered acceptable.
These data take into account vial concentration, calculation
errors, forced rounding errors, volumetric errors of syringe and
inaccuracies in dead space.39
Impact of dosing inaccuracies
Investigation into the clinical impact of inaccuracies to date is
limited. As an example, Parshuram et al49 studied the impact of
unanticipated variation in intravenous methotrexate dosing but
failed to demonstrate a signiﬁcant link between measured total
methotrexate dose given and serum concentration or clinical
toxicities.
Does place of preparation or healthcare professional performing
the preparation have an effect on accuracy?
Errors are commonly found when infusions are prepared at the
point of care13 26 41 52 and improvements are made when a cen-
tralised system for preparation is used.26 47 However, both
methods yield worrying deviations from the required stated
concentrations.
The use of preﬁlled syringes for infusions provides more efﬁ-
cient treatment in an emergency situation than preparation of
the infusions at the bed side; a signiﬁcant reduction in deviation
from the expected concentration was also shown in one com-
parison.25 The same investigation conﬁrmed that precision and
accuracy vary depending on the healthcare professional prepar-
ing the preﬁlled syringes; pharmacists are more accurate than
physicians. Furthermore, a calmer environment for preparation
yields increasing precision as demonstrated by those prepared in
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pharmacy and those sourced from the pharmaceutical indus-
try.25 Previous studies indicated that nurses were less prone to
error introduction in preparation tasks than anaesthetists, but
more errors were introduced at the calculation stage by nurses
than anaesthetists.32 Recently, no differences in the accuracy and
precision of intravitreal dose preparation of 0.05 mL using
1.0 mL disposable syringes57 were noted between nurses and
physicians.
What practices are in place to reduce inaccuracies?
The UK National Patient Safety Agency65 issued an alert
acknowledging the risk associated with injectable medicines and
recommended risk assessment for all injectables, although it has
been argued that the developed tool did not speciﬁcally consider
the issues faced when preparing intravenous medicines for chil-
dren and neonates.66
No speciﬁc guidance on how to manage issues of inaccuracies
is available, so nursing staff have adopted crude methods such
as carrying out dilution in a large syringe after initial measure-
ment of medicine volume (leaving the dead space volume within
the initial syringe),67 using insulin syringes with no dead space
and including the dead space volume in the dose calculation.28
Dead space volume must be considered if drawing up multiple
medicines into the same syringe. If three medicines are drawn
up sequentially, a larger amount of the ﬁrst two will be adminis-
tered. When the second is drawn up, the dead space volume of
the ﬁrst will be released from the hub and needle space into the
graduated portion, to make way for the second, and the same
with the volume of the second as the third is drawn up.63
An investigation into the measurement of insulin using pen
injectors (NovoPen and BD Pen) and syringes has shown that
both device types are inaccurate at measuring 1 unit of insulin
(100 units/mL), with devices improving in accuracy with pro-
gressively larger volumes. This research did not use half unit
pens that are now available. Syringes overdosed and pen injec-
tors consistently underdosed. Pen injectors were signiﬁcantly
more accurate than syringes but variability in dosing was similar
for both.33 Subsequently, improved accuracy of preﬁlled insulin
pens as opposed to vial and syringe methods has been demon-
strated.58 Therefore, pen injectors may be favourable; however,
education is required if patients are transferred between differ-
ent devices.33 Casella et al46 concluded that the error intro-
duced when measuring ≤2 units (100 units/mL) is so large that
dilution of insulin before measurement should be carried out
where possible in an inpatient setting. Furthermore, the smallest
syringe possible is often chosen to measure the required
volume; this has been adapted as a technique and is supported
by evidence.31 48 50 51 In addition, Isaac et al56 explored differ-
ent methods of small volumes measurement of insulin and con-
cluded that all showed inaccuracies; this included dilution and
direct withdrawal with and without priming. For volumes of
≥0.05 mL, direct withdrawal may be more accurate, but dilution
methods show better reproducibility.
The implementation of standardised concentrations of intra-
venous infusions for paediatrics may reduce common inaccur-
acies and errors.13 14 26 64 Implementation of standardised
concentrations in conjunction with other interventions, such as
use of ‘smart’ syringe pumps and relabelling of infusions (for-
matting label information to match pump programming),
resulted in a signiﬁcant reduction in error.37 Improved dosing
precision was conﬁrmed with a paediatric vial containing an
age-appropriate concentration of amikacin in comparison to an
adult vial, with a ﬁvefold higher concentration.27 The concern
over increased cost and confusion between different vial
concentrations likely stands as a barrier to implementation for
different products and hospitals worldwide.
The results of a survey demonstrating acceptability of pro-
posed standard concentrations of 17 medicines, commonly
given by infusion, among 164 critical care units (63% of UK
NHS trusts) have been provided to the Intensive Care Society in
the UK.68 Similar work was carried out in USA by the Institute
for Safe Medicine Practices69 as a result of numerous safety
alerts70 71 and many institutions employ standardised concentra-
tions. Seventeen standardised weight categories and correspond-
ing doses for 74 primarily (86.5%) intravenous medicines were
established for the neonatal population with an aim of reducing
the problems associated with dose delivery in this area.60
Summary
The requirement to measure small volumes, for both oral and
intravenous use, occurs frequently in paediatric settings. There
is a substantial source of error involved in all stages of prepar-
ation of doses involving the use of such volumes. The errors
introduced translate into discrepancies between the concentra-
tions of drugs that are prescribed and the concentrations that
are administered. Much literature describes deviations in the
concentration of opiates for infusion. This occurs whether
medicine is prepared at ward or pharmacy level. Published
research has concluded the requirement of paediatric standar-
dised infusion concentrations, but it is questionable how realistic
this is for all settings. Although pharmacy and industry-sourced
preﬁlled syringes are used in some settings, it is not realistic for
all scenarios. Further, it is highly unlikely that these devices
would appear with appropriate dosing for paediatrics and thus
manipulation prior to use would still be required. Further work
is needed to establish the most accurate methods for handling
small volumes during the administration of medicines to chil-
dren. Risk minimisation strategies, such as speciﬁc training and
additional information at the point of use to support staff
involved, are also necessary.
CONCLUSIONS
This review identiﬁes the need to quantify the sources of error
in preparation of intravenous and enteral medicines, namely
techniques and equipment used, the effects that this may have
on therapy, with an estimation of cost implications. Work
should lead to recommendations that will inform industrial and
clinical aspects of medicine preparation in order to improve
current practice and reduce these inaccuracies. It is hoped that
this review of the extant data will pave the way for the future
development of standardised concentrations of commonly used
medicines in all settings including paediatrics. However, there
will undoubtedly forever be a requirement for preparation and
use of small volumes for drug delivery due to the wide range of
dose and medicine requirements in paediatrics.
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